Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06735859 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Eating Window and Sleep Disorders on Glycemic Control, Cardiovascular Risk, and Weight Loss

StatusActive, Not Recruiting
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Minor Trial status changed: Recruiting → Active, Not Recruiting
    • Enrollment increased: 32 → 40 participants
    • Eligibility criteria expanded, about 75 words
    • Secondary endpoints: 30 to 31
    v10
  2. Minor Trial status: Recruiting to Active, Not Recruiting
    • Enrollment target: estimated 32 to confirmed 40
    • Site details revised
    v9
  3. Minor Start date: Jan 2026 to Jan 21, 2026v8
  4. Notable Enrollment target: 48 to 32v7 Show 6 more changesShow less
    • Start date: Nov 2025 to Jan 2026
    • Primary endpoints: 24 to 1
    • Primary completion date: Nov 19, 2027 to Jun 2027
    • Study completion date: Nov 19, 2027 to Oct 2027
    • Secondary endpoints: 2 to 30
    • Study description expanded, about 8 words
  5. Notable Trial status: Not Yet Recruiting to Recruitingv6 Show 4 more changesShow less
    • Start date: Sep 17, 2025 to Nov 2025
    • Primary completion date: Aug 19, 2027 to Nov 19, 2027
    • Secondary endpoints expanded, about 12 words
    • Site details revised
Show 4 earlier versionsHide 4 earlier versions
  1. Notable Start date: Feb 17, 2025 to Sep 17, 2025
    • Trial status: Recruiting to Not Yet Recruiting
    • Site details revised
    v5
  2. Minor Re-verified, no change to tracked fieldsv4
  3. Notable Trial status: Not Yet Recruiting to Recruitingv3 Show 4 more changesShow less
    • Primary completion date: Dec 1, 2026 to Aug 19, 2027
    • Study sites: 0 to 1
    • Study completion date: Dec 1, 2027 to Nov 19, 2027
    • Start date changed from estimate of Feb 1, 2025 to Feb 17, 2025
  4. Notable Primary endpoints revised (24)v2
  1. Minor Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
8,786 trials monitored
See 412 trials at risk
5,087 trials monitored
See 222 trials at risk
3,874 trials monitored
See 152 trials at risk
and 2 more diseases
This project aims to offer a quantitative and qualitative nutritional approach, along with educational nutritional guidelines for participants with Non-Communicable Chronic Diseases. The main goals are: 1- Regularization of eating habits and windows; 2- Modulation of biochemical, anthropometric, and cardiovascular parameters; 3- Increase in knowledge about healthy eating. In this way, participants will undergo a complete nutritional assessment, comprising anthropometry, biochemistry, clinical, and dietary evaluations.
Trial Details
NCT Number NCT06735859
Lead Sponsor Federal University of São Paulo
Collaborators: Sao Jose do Rio Preto Medical School
Conditions
(from sponsor)
Type 2 Diabetes Mellitus (T2DM), Hypertension, Obesity and Type 2 Diabetes, Cardiovascular Diseases
Related terms Cardiovascular Diseases, Diabetes Mellitus, Type 2, Hypertension, Obesity
Enrollment 40 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov